Finance

Lists
RHHVF:OTCMKTS
Roche Holding AG Genussscheine
US$ ४३८.०७
+१.८०%
(+७.७५) 1D
अक्टोबर १३, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RHHVF...
Open
US$ ४३४.००
High
US$ ४४५.००
Low
US$ ४३०.००
Mkt. cap
३.५० खरब
Avg. vol.
४.७३ हजार
Volume
२२३.००
52-wk high
US$ ४९०.३३
52-wk low
US$ ३१८.८१
Beta
०.५१
Shares outstanding
७०.२६ करोड
No. of employees
१ लाख
Open
US$ ४३४.००
High
US$ ४४५.००
Low
US$ ४३०.००
Mkt. cap
३.५० खरब
Avg. vol.
४.७३ हजार
Volume
२२३.००
52-wk high
US$ ४९०.३३
52-wk low
US$ ३१८.८१
Beta
०.५१
Shares outstanding
७०.२६ करोड
No. of employees
१ लाख
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
४ घण्टा पहिले
Hapvida signs Roche deal: target for Hapvida stock falls 10.77 percent
Euronext Markets: Real-time Stock Market Data | live
Euronext Markets: Real-time Stock Market Data | live
·
१३ घण्टा पहिले
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
ad-hoc-news.de
ad-hoc-news.de
·
१५ घण्टा पहिले
Roche Holding stock rises 3.44 percent on SIX
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees१.१३ लाख
Founded१८९६ अक्टोबर १
Headquartersबेसेल, Basel City, स्विट्जरल्यान्ड
Sector-
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१५.७५ अरब
१५.७५ अरब
१५.७३ अरब
१५.७३ अरब
Cost of goods sold
४.२१ अरब
४.२१ अरब
३.९३ अरब
३.९३ अरब
Cost of revenue
४.२१ अरब
४.२१ अरब
३.९३ अरब
३.९३ अरब
Research and development expenses
३.१५ अरब
३.१५ अरब
२.९९ अरब
२.९९ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.५९ अरब
३.५९ अरब
३.२२ अरब
३.२२ अरब
Operating expense
६.८२ अरब
६.८२ अरब
६.११ अरब
६.११ अरब
Total operating expenses
११.०३ अरब
११.०३ अरब
१०.०३ अरब
१०.०३ अरब
Operating income
४.७२ अरब
४.७२ अरब
५.६९ अरब
५.६९ अरब
Other non operating income
-१.०० करोड
-१.०० करोड
-१.५० करोड
-१.५० करोड
EBT including unusual items
३.६९ अरब
३.६९ अरब
४.४९ अरब
४.४९ अरब
EBT excluding unusual items
४.३७ अरब
४.३७ अरब
५.३८ अरब
५.३८ अरब
Income tax expense
७०.९० करोड
७०.९० करोड
८२.४० करोड
८२.४० करोड
Effective tax rate
१९.२०%
१९.२०%
१८.३७%
१८.३७%
Other operating expenses
७.७५ करोड
७.७५ करोड
-९.९० करोड
-९.९० करोड
Net income
२.७४ अरब
२.७४ अरब
३.४४ अरब
३.४४ अरब
Net profit margin
१७.३६%
१७.३६%
२१.८५%
२१.८५%
Earnings per share
-
-
-
-
Interest and investment income
४.५० करोड
४.५० करोड
४.३५ करोड
४.३५ करोड
Interest expense
-२८.९५ करोड
-२८.९५ करोड
-२८.२० करोड
-२८.२० करोड
Net interest expenses
-२४.४५ करोड
-२४.४५ करोड
-२३.८५ करोड
-२३.८५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
५.५० अरब
५.५० अरब
६.४८ अरब
६.४८ अरब
Gain or loss from assets sale
-२.१५ करोड
-२.१५ करोड
-२५.०० लाख
-२५.०० लाख
AI content may include mistakes. Learn more
Google एपहरू